More than 90% of lung infections in cystic fibrosis (CF) patients are caused by Pseudomonas aeruginosa [1]; further CF pathogens include clinical isolates of Burkholderia cepacia, Staphylococcus aureus and Stenotrophomonas maltophilia, a newly emerging pathogen [2]. Current therapies are targeted at reducing obstruction, inflammation, or infection, but pathogenic bacteria easily develop resistance to conventional antibiotics [3]. Such molecules affect vital microbial functions through recognition and interaction with specific targets involved in metabolic reactions within cells. The susceptibility of these target molecules to mutations makes it easy for the microbes to become resistant to antibiotics. This strongly encourages the quest of novel antimicrobials especially for the treatment of chronic infections.

A Trans-Kingdom Antimicrobial Peptide Targeting Cystic Fibrosis Pathogens / Pedone, EMILIA MARIA; Notomista, Eugenio; Galdiero, Stefania; Varcamonti, Mario; Contursi, Patrizia. - In: JOURNAL OF GENETIC SYNDROMES & GENE THERAPY. - ISSN 2157-7412. - 7:(2016), pp. 5-7. [10.4172/2157-7412.1000308]

A Trans-Kingdom Antimicrobial Peptide Targeting Cystic Fibrosis Pathogens

PEDONE, EMILIA MARIA;NOTOMISTA, EUGENIO;GALDIERO, STEFANIA;VARCAMONTI, MARIO;CONTURSI, PATRIZIA
2016

Abstract

More than 90% of lung infections in cystic fibrosis (CF) patients are caused by Pseudomonas aeruginosa [1]; further CF pathogens include clinical isolates of Burkholderia cepacia, Staphylococcus aureus and Stenotrophomonas maltophilia, a newly emerging pathogen [2]. Current therapies are targeted at reducing obstruction, inflammation, or infection, but pathogenic bacteria easily develop resistance to conventional antibiotics [3]. Such molecules affect vital microbial functions through recognition and interaction with specific targets involved in metabolic reactions within cells. The susceptibility of these target molecules to mutations makes it easy for the microbes to become resistant to antibiotics. This strongly encourages the quest of novel antimicrobials especially for the treatment of chronic infections.
2016
A Trans-Kingdom Antimicrobial Peptide Targeting Cystic Fibrosis Pathogens / Pedone, EMILIA MARIA; Notomista, Eugenio; Galdiero, Stefania; Varcamonti, Mario; Contursi, Patrizia. - In: JOURNAL OF GENETIC SYNDROMES & GENE THERAPY. - ISSN 2157-7412. - 7:(2016), pp. 5-7. [10.4172/2157-7412.1000308]
File in questo prodotto:
File Dimensione Formato  
a-transkingdom-antimicrobial-peptide-targeting-cystic-fibrosis-pathogens-2157-7412-1000308.pdf

solo utenti autorizzati

Licenza: Accesso privato/ristretto
Dimensione 610.04 kB
Formato Adobe PDF
610.04 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/650952
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact